A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation

Published:2006-01-20 Issue:10 Volume:13 Page:1789-1801
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Georgopoulos N T,Steele L P,Thomson M J,Selby P J,Southgate J,Trejdosiewicz L K

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/4401859.pdf

Reference47 articles.

1. Gordon J and Pound JD (2000) Fortifying B cells with CD154: an engaging tale of many hues. Immunology 100: 269–280

2. Tong AW and Stone MJ (2003) Prospects for CD40-directed experimental therapy of human cancer. Cancer Gene Ther. 10: 1–13

3. Gordon J (1995) CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation. Blood Rev. 9: 53–56

4. Johnson PW, Watt SM, Betts DR, Davies D, Jordan S, Norton AJ and Lister TA (1993) Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 82: 1848–1857

5. Schattner EJ, Mascarenhas J, Bishop J, Yoo DH, Chadburn A, Crow MK and Friedman SM (1996) CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells. Blood 88: 1375–1382

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of key molecular pathways and genes in BRCA1 and BRCA2-mutant ovarian cancer: evidence from bioinformatics analysis;Genome Instability & Disease;2024-07-12

2. CD40 stimulation via CD40 ligand enhances adenovirus‐mediated tumour immunogenicity including ‘find‐me’, ‘eat‐me’, and ‘kill‐me’ signalling;Journal of Cellular and Molecular Medicine;2024-03-17

3. Decoding the contextual duality of CD40 functions;Human Immunology;2023-11

4. FAM111B Acts as an Oncogene in Bladder Cancer;Cancers;2023-10-24

5. The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy;Frontiers in Immunology;2023-05-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3